WHO adopts antibodies created by Lankenau researchers as a standard to ensure quality control of polio vaccines worldwide
WYNNEWOOD, Pa., Dec. 9, 2022. Human antibodies cloned by scientists at the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, have been adopted by the World Health Organization as a crucial part of its plan to permanently... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 9, 2022 Category: Pharmaceuticals Source Type: clinical trials

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Condition:   Poliomyelitis Interventions:   Biological: Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1);   Biological: Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1) Sponsors:   PATH;   Bill and Melinda Gates Foundation;   PT Bio Farma;   Centers for Disease Control and Prevention;   DiagnoSearch Life Sciences Pvt. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials